Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Recruiting in Palo Alto (17 mi)
+164 other locations
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Celgene
No Placebo Group
Trial Summary
What is the purpose of this trial?
The purpose of the Connect™ Chronic Lymphocytic Leukemia (CLL) Disease Registry is to explore the history and real world management of patients diagnosed with CLL, provide insight into the management of CLL, and evaluate the effectiveness of first, second and subsequent therapeutic strategies employed in both the community and academic settings.
Research Team
KF
Kenneth Foon, MD
Principal Investigator
Celgene Corporation
Eligibility Criteria
Inclusion Criteria
Clinical diagnosis with CLL
Age≥18 years
Clinical decision made to initiate first-line therapy, second-line therapy or subsequent line of therapy prior to enrollment into the ConnectTM CLL registry, but within 2 months of enrollment
See 2 more
Treatment Details
Interventions
- None ()
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
St. Joseph Oncology, Inc.Saint Joseph, MO
Southeast Nebraska Hematology & Oncology Consultants, PCLincoln, NE
Drs. Forte, Schleider, Attas & Condemi, PAEnglewood, NJ
Eduardo Saponara, MDBronxville, NY
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Celgene
Lead Sponsor
Trials
649
Patients Recruited
130,000+
Top Products
>- **Revlimid (lenalidomide)**: Multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma treatment.
- **Pomalyst (pomalidomide)**: Relapsed/refractory multiple myeloma treatment.
- **Otezla (apremilast)**: Psoriatic arthritis treatment.
- **Thalomid (thalidomide)**: Erythema nodosum leprosum and multiple myeloma treatment.